Evidence map›Paper›PMID 33050415›Full record

ReviewInternational journal of molecular sciences2020

The Diverse Roles of TAO Kinases in Health and Diseases.

Chih-Yeu Fang, Tsung-Ching Lai, Michael Hsiao, Yu-Chan Chang

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 74 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Expanding the phenotype and genotype spectrum of TAOK1 neurodevelopmental disorder and delineating TAOK2 neurodevelopmental disorder.Genetics in medicine : official journal of the American College of Medical Genetics · 2025
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Chih-Yeu FangGenomics Research Center, Academia Sinica, Taipei 115, Taiwan.
Tsung-Ching LaiDivision of Pulmonary Medicine, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei 116, Taiwan.
Michael HsiaoGenomics Research Center, Academia Sinica, Taipei 115, Taiwan.
Yu-Chan ChangDepartment of Biomedical Imaging and Radiological Science, National Yang-Ming University, Taipei 112, Taiwan.
Genomics Research Center, Academia Sinica · TWKaohsiung Medical University · TWNational Yang Ming Chiao Tung University · TWWan Fang Hospital · TW

Funding

Academia Sinica [AS-SUMMIT-108], [AS-SUMMIT-109], [ASKPQ-109-BioMed]Ministry of Science and Technology, Taiwan [MOST-107-2320-B-001-016-MY3], [MOST-108-3114-Y-001-002]
6 · The paper itself

Abstract

Thousand and one kinases (TAOKs) are members of the MAP kinase kinase kinase (MAP3K) family. Three members of this subfamily, TAOK1, 2, and 3, have been identified in mammals. It has been shown that TAOK1, 2 and 3 regulate the p38 MAPK and Hippo signaling pathways, while TAOK 1 and 2 modulate the SAPK/JNK cascade. Furthermore, TAOKs are involved in additional interactions with other cellular proteins and all of these pathways modulate vital physiological and pathophysiological responses in cells and tissues. Dysregulation of TAOK-related pathways is implicated in the development of diseases including inflammatory and immune disorders, cancer and drug resistance, and autism and Alzheimer's diseases. This review collates current knowledge concerning the roles of TAOKs in protein-protein interaction, signal transduction, physiological regulation, and pathogenesis and summarizes the recent development of TAOK-specific inhibitors that have the potential to ameliorate TAOKs' effects in pathological situations.

Indexed as

Disease SusceptibilityHealthAnimalsCarrier ProteinsDrug DevelopmentHomeostasisHumansPhosphorylationProtein BindingProtein Kinase InhibitorsProtein Serine-Threonine KinasesSignal TransductionStructure-Activity RelationshipCarrier ProteinsProtein Kinase InhibitorsProtein Serine-Threonine KinasesHippop38 MAPKSAPK/JNKTAOKthousand and one kinase

Identifiers

PMID33050415
PMCPMC7589832
OpenAlexW3091782610

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.